Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature.

Gabr, Jihad Ben; Liu, Eric; Mian, Sundus; Pillittere, Julie; Bonilla, Eduardo; Banki, Katalin; Perl, Andras

Gabr, Jihad Ben; Liu, Eric; Mian, Sundus; Pillittere, Julie; Bonilla, Eduardo; Banki, Katalin; Perl, Andras.

Afiliación

Gabr JB; Department of Medicine, Upstate Medical University, College of Medicine, Syracuse, NY, USA.
Liu E; Department of Medicine, Upstate Medical University, College of Medicine, Syracuse, NY, USA.
Mian S; Department of Medicine, Upstate Medical University, College of Medicine, Syracuse, NY, USA.
Pillittere J; Department of Medicine, Upstate Medical University, College of Medicine, Syracuse, NY, USA.
Bonilla E; Department of Medicine, Upstate Medical University, College of Medicine, Syracuse, NY, USA.
Banki K; Department of Pathology, State University of New York, College of Medicine, Syracuse, NY, USA.
Perl A; Department of Medicine, Upstate Medical University, College of Medicine, Syracuse, NY, USA.

Ann Transl Med ; 8(14): 887, 2020 Jul.

Article en En | MEDLINE | ID: mdl-32793731

Palabras clave

Macrophage activation syndrome (MAS); adult onset Still's disease (AOSD); emapalumab; hemophagocytic lymphohistiocytosis (HLH); interferon gamma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Ann Transl Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google